A $4.7bn verdict awarded to 22 women who claim Johnson & Johnson’s talc products were contaminated with asbestos has led to questions around potential insurance exposures during second quarter earnings calls.
A $4.7bn verdict awarded to 22 women who claim Johnson & Johnson’s talc products were contaminated with asbestos has led to questions around potential insurance exposures during second quarter earnings calls.